VirTech Bio
Beverly
About VirTech Bio
Provider of a healthcare research technology platform intended to develop innovative therapies for organ preservation, ex-vivo organ management and bioengineered organ. The company's healthcare research technology platform combines machine perfusion with hemoglobin-based oxygen carrier for organ and tissue preservation and biomarker discovery, enabling healthcare organizations to increase organ utilization, decrease organ discard rate and enhance transplant outcomes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $20.4M
- Funding stage: Seed
- Last round: Grant (Nov 2022)
- Website: virtechbio.com
- Phone: [email protected]
Industries & Categories
Health Care, Information Technology
Canonical: https://fsome.com/organization/virtech-bio-109203 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.